Uniplan Investment Counsel Inc. Sells 508 Shares of Psychemedics Corporation (PMD)
Uniplan Investment Counsel Inc. lowered its holdings in Psychemedics Corporation (NASDAQ:PMD) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 253,651 shares of the company’s stock after selling 508 shares during the quarter. Uniplan Investment Counsel Inc. owned approximately 4.65% of Psychemedics Corporation worth $6,329,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Carl Domino Inc grew its position in shares of Psychemedics Corporation by 0.6% in the 2nd quarter. Carl Domino Inc now owns 14,485 shares of the company’s stock worth $361,000 after buying an additional 92 shares during the last quarter. Janney Montgomery Scott LLC grew its position in shares of Psychemedics Corporation by 14.2% in the 2nd quarter. Janney Montgomery Scott LLC now owns 14,218 shares of the company’s stock worth $355,000 after buying an additional 1,767 shares during the last quarter. Algert Global LLC grew its position in shares of Psychemedics Corporation by 2.5% in the 2nd quarter. Algert Global LLC now owns 54,761 shares of the company’s stock worth $1,366,000 after buying an additional 1,350 shares during the last quarter. Blair William & Co. IL grew its position in shares of Psychemedics Corporation by 6.2% in the 2nd quarter. Blair William & Co. IL now owns 127,462 shares of the company’s stock worth $3,180,000 after buying an additional 7,490 shares during the last quarter. Finally, Crawford Investment Counsel Inc. grew its position in shares of Psychemedics Corporation by 5.1% in the 2nd quarter. Crawford Investment Counsel Inc. now owns 189,233 shares of the company’s stock worth $4,721,000 after buying an additional 9,100 shares during the last quarter. Institutional investors and hedge funds own 57.93% of the company’s stock.
In other Psychemedics Corporation news, VP Michael I. Schaffer sold 7,548 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $20.41, for a total transaction of $154,054.68. Following the sale, the vice president now owns 41,273 shares of the company’s stock, valued at $842,381.93. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Michael I. Schaffer sold 4,400 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $20.37, for a total transaction of $89,628.00. Following the sale, the vice president now directly owns 41,273 shares in the company, valued at approximately $840,731.01. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,929 shares of company stock worth $264,441. 8.60% of the stock is owned by corporate insiders.
Shares of Psychemedics Corporation (PMD) traded down 1.0734% on Tuesday, hitting $18.5982. 6,721 shares of the stock were exchanged. Psychemedics Corporation has a 52-week low of $13.81 and a 52-week high of $27.99. The stock has a market cap of $102.12 million, a PE ratio of 13.7256 and a beta of 1.02. The company’s 50 day moving average is $21.85 and its 200-day moving average is $21.62.
Psychemedics Corporation (NASDAQ:PMD) last issued its earnings results on Wednesday, August 2nd. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $9.68 million for the quarter. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%. Analysts predict that Psychemedics Corporation will post $0.93 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, August 24th. Investors of record on Monday, August 14th were issued a $0.15 dividend. The ex-dividend date of this dividend was Thursday, August 10th. This represents a $0.60 annualized dividend and a yield of 3.19%. Psychemedics Corporation’s dividend payout ratio (DPR) is 44.44%.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/09/12/uniplan-investment-counsel-inc-sells-508-shares-of-psychemedics-corporation-pmd.html.
About Psychemedics Corporation
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.
Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.